Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blaise

Showing results (1-10 of 284) with videos related to

Pageof 29
Sort By:
Hematology and Cell Therapy|October 1, 1996
[Peripheral blood stem cell allograft]D Blaise
Leukemia Research|January 28, 1999
Interleukin 2 in the treatment of acute leukemiaD Blaise, D Maraninchi
La Revue De Medecine Interne|January 11, 2005
[Immunotherapy with allogeneic haematopoietic stem cell transplantation: current status and perspectives]M Mohty, C Faucher, D Blaise
Bone Marrow Transplantation|April 5, 2016
Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosisC Saillard, D Blaise, D Mokart
Lancet (London, England)|January 2, 1993
Long-term follow-up of T-cell depletion for bone marrow transplantationD Blaise, G Gravis, D Maraninchi
Leukemia|January 28, 2005
Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantationM Mohty, C Faucher, D Blaise
Presse Medicale (Paris, France : 1983)|October 26, 1988
[Ceftazidime after bone marrow graft. Current aspects]D Blaise, D Maraninchi, A M Stoppa
La Revue Du Praticien|March 1, 1993
[Cytokines and malignant hemopathies: leukemias and bone marrow graft]D Blaise, A M Stoppa, D Maraninchi
Bone Marrow Transplantation|October 27, 2004
rhG-CSF does not affect the phenotype of adult donor peripheral blood NK cellsF Lassailly, I Sielleur, D Blaise, et al.
Bone Marrow Transplantation|February 23, 2010
Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioningT Prébet, R Devillier, S Fürst, et al.
Pageof 29

Showing results (1-10 of 284) with videos related to

Sort By:
Pageof 29
Hematology and Cell Therapy|October 1, 1996
[Peripheral blood stem cell allograft]D Blaise
Leukemia Research|January 28, 1999
Interleukin 2 in the treatment of acute leukemiaD Blaise, D Maraninchi
La Revue De Medecine Interne|January 11, 2005
[Immunotherapy with allogeneic haematopoietic stem cell transplantation: current status and perspectives]M Mohty, C Faucher, D Blaise
Bone Marrow Transplantation|April 5, 2016
Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosisC Saillard, D Blaise, D Mokart
Lancet (London, England)|January 2, 1993
Long-term follow-up of T-cell depletion for bone marrow transplantationD Blaise, G Gravis, D Maraninchi
Leukemia|January 28, 2005
Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantationM Mohty, C Faucher, D Blaise
Presse Medicale (Paris, France : 1983)|October 26, 1988
[Ceftazidime after bone marrow graft. Current aspects]D Blaise, D Maraninchi, A M Stoppa
La Revue Du Praticien|March 1, 1993
[Cytokines and malignant hemopathies: leukemias and bone marrow graft]D Blaise, A M Stoppa, D Maraninchi
Bone Marrow Transplantation|October 27, 2004
rhG-CSF does not affect the phenotype of adult donor peripheral blood NK cellsF Lassailly, I Sielleur, D Blaise, et al.
Bone Marrow Transplantation|February 23, 2010
Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioningT Prébet, R Devillier, S Fürst, et al.
Pageof 29